Jammbe Musoro

@Jammbe_Musoro

Statistician/expert in quality of life, PhD,

Vrijeme pridruživanja: travanj 2017.

Tweetovi

Blokirali ste korisnika/cu @Jammbe_Musoro

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Jammbe_Musoro

  1. proslijedio/la je Tweet
    31. sij
    Poništi
  2. proslijedio/la je Tweet
    30. lis 2019.

    Excited to present at this meeting and advocate our agile measurement using our QoL questionnaires and the Central = !

    Poništi
  3. proslijedio/la je Tweet
    27. lis 2019.

    We are pleased to announce Interstellar 4.0 (Voyager), the latest version of our app. 12 new languages, new UI, improved security, improved trading UI, powerful SEP6 & SEP10 support, the All Spark & more!Available online at . Mobile & desktop apps to follow

    , , i još njih 2
    Poništi
  4. proslijedio/la je Tweet
    24. lis 2019.

    Congratulations Corneel for sharing the SISAQOL work. Its been a great collaboration and special thanks to ISOQOL for being a partner of SISAQOL. We cant wait for the main paper to come out in Lancet Oncology soon.

    Poništi
  5. proslijedio/la je Tweet
    25. lis 2019.

    Do not miss "The 18-year-old trial inclusion limit is a major barrier in the access to clinical trials for adolescents and young adults (AYAs) with " poster presentation of Dr. de Rojas at 6:30PM

    Poništi
  6. proslijedio/la je Tweet
    23. lis 2019.

    poster reporting standardized statistical analysis for in an . Looking forward the published finalized recommendations very soon!

    Poništi
  7. proslijedio/la je Tweet
    23. lis 2019.

    Dagmara Kulis: Developing a comprehensible and translatable questionnaire for cognitively vulnerable populations requires a rigorous process involving various experts, patients and proxies.

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    22. lis 2019.

    EORTC QLQ-F17 is now available, enabling users to measure functioning scales from the QLQ-C30 with other EORTC modules, item lists and other measurement systems.

    Poništi
  9. proslijedio/la je Tweet
    23. lis 2019.

    “Improving standards of patient reported outcomes analysis: matching statistical methods to key research objectives – a SISAQOL initiative”, watch Corneel Coens' itw, Lead Statistician and meet him @ 3:25 PM (GMT-7) 🎬

    Poništi
  10. proslijedio/la je Tweet
    23. lis 2019.

    Watch Dagmara Kulis QOL Translation Team Leader, talk about her poster: “Road to comprehensibility: development and translation of the EORTC IADL-BN32 questionnaire” Meet her @ 3:25 PM (GMT-7) 🎬

    Poništi
  11. proslijedio/la je Tweet
    22. lis 2019.

    Prof Bernhard Holzner: Can using PRO measures improve agreement of CTCAE ratings among clinicians?

    Poništi
  12. proslijedio/la je Tweet
    22. lis 2019.

    There is no single global standard for clinically meaningful change across QLQ-C30 scales and across disease sites. Be thoughtful when choosing MIDs.

    Poništi
  13. proslijedio/la je Tweet
    22. lis 2019.

    Claire Piccinin, QOL Researcher, will talk about “Seeking a Mutual Understanding of Health-Related Quality of Life Domains: Mapping the EORTC QLQ-C30 onto the WHO-ICF” Interested? Meet her @ 3:35 PM (GMT-7) 🎬

    Poništi
  14. proslijedio/la je Tweet
    22. lis 2019.

    statistician talks about his oral presentation “Establishing anchor-based minimally important differences for the EORTC QLQ-C30 scales across multiple cancer sites” His presentation is :45 PM (GMT-7) 🎬

    Poništi
  15. proslijedio/la je Tweet
    21. lis 2019.

    EU GDPR improves protection of patients’ data privacy, but data access for secondary research becomes a challenge. Plan sufficient time & resources.

    Poništi
  16. proslijedio/la je Tweet
    21. lis 2019.

    Specialist in will present her poster @ 3:20 PM (GMT-7) She will talk about the CATAPULT experience, the challenge of using health-related QOL data from cancer clinical trials for retrospective studies 🎬

    Poništi
  17. proslijedio/la je Tweet
    20. lis 2019.

    Hello ! team is here and preparing for ! Looking forward! ❤️

    Poništi
  18. proslijedio/la je Tweet
    8. kol 2019.

    Recent presentations on QOL. Take a look at the entire EORTC QOL conference presentations: all you need to know about QOL and cancer trials. Thanks to all the speakers for

    Poništi
  19. proslijedio/la je Tweet
    17. srp 2019.

    “Extending generalized pairwise comparisons to competing risks allows the analysis of clinical trials in such context with a method providing a global assessment of the treatment effect based on multiple treatment aspects of prime importance to the patients.”

    Poništi
  20. proslijedio/la je Tweet
    16. srp 2019.

    New deadline: 20 July - Help enhancing collaboration within Europe to improve cancer research, fill in this 🔎survey about “Cross-border access to clinical trials in Europe” : ➡️ and Patvocates

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·